FXD First Trust Consumer Discretionary AlphaDEX Fund

Expense Ratio
0.6%
Dividend
0.81%
Previous close
$64.22
Est. 12 months change
+21.92%
Projected Price
$78.30

Profitability Metrics

Return on Equity (ROE)
32.75%
Return on Assets (ROA)
7.15%
Return on Invested Capital (ROIC)
18.70%
Weighted Average Cost of Capital (WACC)
8.48%
ROIC - WACC
10.21%
Updated : 2026-04-04 07:23 ET

Valuation Metrics

P/E Ratio
15.53
Forward P/E
13.47
PEG Ratio
2.05
Debt Current Ratio
1.98

Growth & Cash Flow

Gross Margin
39.72%
Operating Margin
13.64%
FCF Margin
10.42%
TTM Revenue Growth
7.59%
Projected 12M EPS Growth
15.24%

Price Change

Price % from 50 SMA
-4.99%
Price % from 200 SMA
-4.49%
6 Months
-6.15%
1 Year
7.82%
2 Years
2.52%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
SIRI1.84%
TPR1.72%
LEA1.64%
PVH1.60%
PHM1.56%
TOL1.55%
LKQ1.54%
VIK1.54%
TNL1.54%
HOG1.53%

ETF Analysis

Fund Overview

First Trust Consumer Discretionary AlphaDEX Fund (FXD) currently reports 118 stock positions (subject to change), placing it in the index-like in breadth range by holdings breadth. The top line-up is SIRI (1.84%), TPR (1.72%), LEA (1.64%), with SIRI as the largest single weight at 1.84%. Together, the top three holdings account for 5.20%, which reflects a construction where the top positions carry meaningful but not outsized influence on aggregate returns. In aggregate, the construction reflects a balance between directional conviction and the diversification benefits that come from a broader holding set.

Profitability & Capital Efficiency

On the question of capital productivity, ROIC is 18.70%, WACC is 8.48%, and the economic spread is 10.21%. On balance, the economic spread is positive and meaningful, suggesting the underlying holdings are building rather than eroding intrinsic value. Supporting metrics show ROE at 32.75% and ROA at 7.15%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

From a market pricing perspective, trailing P/E of 15.53, forward P/E of 13.47, PEG of 2.05. With trailing and forward P/E closely aligned, the market appears to be pricing the portfolio on the assumption that earnings remain broadly stable near term. On a growth-adjusted basis, valuation appears reasonable relative to expected growth. The portfolio carries an aggregate current ratio of 1.98, consistent with adequate near-term liquidity management. The overall valuation picture is one where the market is paying for a specific earnings and growth outcome — and where any deviation from that path would likely pressure multiples.

Margins & Cash Generation

The margin stack reads as follows: gross margin sits at 39.72%, operating margin at 13.64%, and free cash flow margin at 10.42%. Gross margins are in the moderate range, typical of sectors where direct costs consume a larger share of revenue. The portfolio's operating margins leave limited room between gross profit and operating earnings — a sign of cost pressure. FCF margins are in a reasonable range, though there is room for improvement in how efficiently revenues convert to free cash. The margin profile is a mixed read — some holdings are clearly well-run, but the aggregate numbers point to a basket that is not uniformly high-quality.

Growth & Forward Outlook

The forward view combines two signals: the estimated 12-month price change of 22.14%, where analyst assumptions support a moderate upside case if execution remains steady, while TTM revenue growth of 7.59% suggesting the portfolio's holdings are growing revenues at a measured, sustainable pace. The projected 12-month EPS growth rate of 15.2% is a standout component of the forward case — meaningful earnings expansion at this scale typically warrants attention from growth-oriented investors. One metric reflects operational reality, the other market expectation — both are useful inputs, but neither should be read in isolation. The interaction between revenue execution and analyst repricing will ultimately determine how closely realized returns track current expectations. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Buy

The overall evidence base is constructive, with more signals pointing up than down and no obvious structural impairment to the forward case.

This assessment reflects quantitative metrics only and does not constitute financial advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.